Home > News By Company > RNCOS
Monoclonal Antibodies to Drive Protein Therapeutics Market
Global protein therapeutics market is forecast to grow at a CAGR of around 15% in next three years, says RNCOS in its report.
(EMAILWIRE.COM, November 09, 2009 ) New Delhi, India - A new research report released by RNCOS provides extensive research and analysis on the global protein therapeutics market, giving an insight into the industry’s current and future trends. It evaluates industry performance based upon different market segments.
The protein therapeutics drugs have registered an impressive growth rate worldwide over the last few years. The growth in sales of therapeutics drugs has been supported by increasing prevalence of diseases and higher efficacy of these drugs. According to our research report “Global Protein Therapeutics Market Analysis”, global protein therapeutics market is anticipated to grow at a CAGR of around 15% during 2010-2012.
We have found that Monoclonal Antibody segment will exhibit the highest growth rate amongst all segments, and it will become the key growth driver of the overall industry. Besides this, therapies like insulin, interferon beta are also expected to show significant growth. Our research study provides a complete analysis on these different segments of the therapeutics market. Also, it studies the therapeutic industry in a way which will help the client in deeply understanding the technical aspects of the industry. Besides this, it provides detailed information on several products related to different segments along with their annual sales values.
The report studies the market by analyzing certain macro and micro economic factors associated with the industry and providing boost to the market growth. Moreover, our report identifies certain key emerging market trends, which are developing in line with the industry growth.
“Global Protein Therapeutics Market Analysis” also provides business profile of the key competitors in the market. This will give our clients an additional edge in the market. Overall, our research study provides valuable information to clients looking to venture into different segments of therapeutics market and helps them to devise strategies while going for an investment/partnership in these markets.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
The protein therapeutics drugs have registered an impressive growth rate worldwide over the last few years. The growth in sales of therapeutics drugs has been supported by increasing prevalence of diseases and higher efficacy of these drugs. According to our research report “Global Protein Therapeutics Market Analysis”, global protein therapeutics market is anticipated to grow at a CAGR of around 15% during 2010-2012.
We have found that Monoclonal Antibody segment will exhibit the highest growth rate amongst all segments, and it will become the key growth driver of the overall industry. Besides this, therapies like insulin, interferon beta are also expected to show significant growth. Our research study provides a complete analysis on these different segments of the therapeutics market. Also, it studies the therapeutic industry in a way which will help the client in deeply understanding the technical aspects of the industry. Besides this, it provides detailed information on several products related to different segments along with their annual sales values.
The report studies the market by analyzing certain macro and micro economic factors associated with the industry and providing boost to the market growth. Moreover, our report identifies certain key emerging market trends, which are developing in line with the industry growth.
“Global Protein Therapeutics Market Analysis” also provides business profile of the key competitors in the market. This will give our clients an additional edge in the market. Overall, our research study provides valuable information to clients looking to venture into different segments of therapeutics market and helps them to devise strategies while going for an investment/partnership in these markets.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




